BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim TH, Kim H, Kim IC. The potential of cystatin-C to evaluate the prognosis of acute heart failure: A comparative study. Acute Card Care 2015;17:72-6. [PMID: 27494366 DOI: 10.1080/17482941.2016.1203440] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen S, Tang Y, Zhou X. Cystatin C for predicting all-cause mortality and rehospitalization in patients with heart failure: a meta-analysis. Biosci Rep 2019;39:BSR20181761. [PMID: 30643006 DOI: 10.1042/BSR20181761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Benoit SW, Ciccia EA, Devarajan P. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev Mol Diagn 2020;20:1019-26. [PMID: 32450046 DOI: 10.1080/14737159.2020.1768849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev 2021. [PMID: 33852110 DOI: 10.1007/s10741-021-10105-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kumrić M, Borovac JA, Kurir TT, Božić J. Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review. Life (Basel) 2021;11:53. [PMID: 33466609 DOI: 10.3390/life11010053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Manguba AS, Vela Parada X, Coca SG, Lala A. Synthesizing Markers of Kidney Injury in Acute Decompensated Heart Failure: Should We Even Keep Looking? Curr Heart Fail Rep 2019;16:257-73. [DOI: 10.1007/s11897-019-00448-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Ruan Z, Chen G, Ren Y, Zhu L. Prediction efficiency of serum cystatin C for clinical outcome in patients with cardiac resynchronization therapy. Ir J Med Sci 2018;187:909-14. [DOI: 10.1007/s11845-018-1771-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Huang G, Qin J, Deng X, Luo G, Yu D, Zhang M, Zhou S, Wang L. Prognostic value of serum uric acid in patients with acute heart failure: A meta-analysis. Medicine (Baltimore) 2019;98:e14525. [PMID: 30813158 DOI: 10.1097/MD.0000000000014525] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
8 Berezin AE. Circulating Biomarkers in Heart Failure. Adv Exp Med Biol 2018;1067:89-108. [PMID: 29392578 DOI: 10.1007/5584_2017_140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L, Acheampong E, Zhengcan Z, Xiaoyan Q, Yunsheng X, Jingyuan M, Xiumei G, Guanwei F. Biomarkers in heart failure: the past, current and future. Heart Fail Rev. 2019;24:867-903. [PMID: 31183637 DOI: 10.1007/s10741-019-09807-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]